Remote Patient Monitoring and Telehealth: 5 Years of Growth Forecast for $54 Billion Market
Share Article
Healthcare publisher, Kalorama Information, shares insights from its recent report on the remote patient monitoring and telehealth market.
There is a new focus on pandemic preparedness and in-place infrastructure development for quick deployment of remote care technologies, which have made telehealth among the most cost-effective ways for the healthcare industry to meet the evolving requirements of patients. ARLINGTON, Va. (PRWEB) May 11, 2021 Before COVID-19, the telehealth industry was evolving slowly with slight gains annually. Today, the pandemic has thrust the world into a new era of remote life, including managing, monitoring and treating patients and their health conditions at a pace never experienced before. As a result of COVID-19, the global market for patient monitoring and telehealth increased by
3 Growth Trends in $472 Billion Global Medical Device Market
Share Article
Healthcare publisher, Kalorama Information, shares insights from its recent report on the global medical device market.
COVID-19 related product demand impacted all markets, all regions, and all vendors to some degree in 2020, continuing through the first part of 2021. ARLINGTON, Va. (PRWEB) May 05, 2021 The global market for medical devices rose to $472 billion in 2020, increasing 5.1% for the year over 2019, according to new data published in The Global Market for Medical Devices, 11th Edition, the latest report by leading medical market research firm Kalorama Information. The coronavirus pandemic in particular had a notable impact on medical device sales.
At-Home Testing Expanding Reach Beyond COVID-19 Pandemic
Share Article
Healthcare publisher, Kalorama Information, shares insights from its recent report on the at home testing market.
Rapid diagnosis, such as what is offered through at-home testing, is also key to containing outbreaks by allowing for efficient contact tracing in communities. ARLINGTON, Va. (PRWEB) April 27, 2021 Over the years, the increasing introduction of transportable, portable, and handheld medical instruments has resulted in the migration of point-of-care (POC) testing from the hospital environment to a range of medical and non-medical environments including the workplace, home, disaster care and most recently, convenience clinics. In the face of the ongoing global COVID-19 pandemic, the reliance upon and need for testing without the direct involvement of healthcare professionals has become arguably more important now than ever before, ac
Point of Care Test Market is Ravaged, and Helped By Pandemic
News provided by
Share this article
Share this article
ARLINGTON, Va., April 20, 2021 /PRNewswire/ Kalorama Information reported a mixed result with point of care testing, defined by tests that can deliver a result meaningful during a patient visit with a provider or on their own. In 2020, sales of POC testing reached $29,316 million, according to Kalorama Information, a sister publication to Lab Pulse. That s up double digits from 2019, which would normally be pretty intense growth according to the Arlington, VA-based producer of IVD market research reports, but the growth in sales belies the reduction of business for the average point-of-care test product. New COVID-19 tests fueled growth while the pandemic ravaged business in other test categories. This according to Kalorama s Information Worldwide Market for Point of Care.
Arlington, VA (PRWEB) April 16, 2021 Total global sales of biomarker test products are projected to reach nearly $63 billion in 2027 with the majority of